BRAFTOVI – (Encorafenib)

Braftovi is an anticancer medicine that contains encorafenib as the active substance. It is used in combination with another medicine that contains binimetinib, to treat adult patients with a type of skin cancer called melanoma.

When Braftovi is used in combination with binimetinib, which targets another protein that stimulates cancer cell growth, the combination slows or even stops the growth of the cancer. Braftovi is also used in combination with another medicine that contains cetuximab, to treat adult patients with a type of colorectal cancer.